Skip to main content

Advertisement

Log in

Urinary tract infections in patients with rheumatoid arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Co-morbidity from rheumatoid arthritis (RA) has recently focussed on outcomes of cardiovascular and pulmonary disease, but serious infections are an increasingly well-recognised complication of RA. Recent work has demonstrated how the incidence of pneumonia can be reduced in RA, but little attention has been paid to the incidence of urinary tract infection (UTI) in RA or to the associated co-morbidity. The aim of this study was to describe the incidence of UTI leading to hospitalisation in a large cohort of patients with RA and investigate which factors contributed to this. This study assessed all patients with RA hospitalised over a 12-month period with a discharge diagnosis including UTI. Patients were identified through a PAS records search in a single large centre. Historical case controls without RA matched for age and gender were identified from the literature. Clinical notes were manually examined by two observers. We recorded: age, gender, duration of RA, number of UTI, all RA therapy, co-morbidity, results of urine and blood cultures with antimicrobial sensitivities, readmission rates, treatment and outcome. We calculated the relative risk (RR) of developing UTI in patients with RA and the factors influencing this. From a population of 2,200 RA patients, the overall annual incidence of hospitalisation with UTI amongst RA patients was 2.09 %, as against 0.97 and 0.91 % for two control groups (RR = 2.16 and 2.29). Most patients (90 %) were female, and the group mean age was 76 years. The use of long-term oral steroids as sole therapy was associated with a RR of 6.8 for UTI (p = 0.002) while failure to take disease-modifying anti-rheumatic drugs (DMARDs) was associated with a similar RR of 6.7 (p = 0.001). Positive cultures for Escherichia coli were found in 51 % of RA patients. Relevant co-morbidities included permanent catheters, vaginal prolapse, cancer and diabetes. Recurrence of UTI within a year was common. RA was associated with a higher-than-expected incidence of UTI, particularly among older females. This was associated with the use of long-term oral steroids and the absence of DMARDs. Other factors included female gender, greater age and long disease duration. We recommend avoidance of long-term oral steroids but consideration of low-dose prophylactic antibiotics in those patients with recurrent UTI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S et al (2007) Mortality in rheumatoid arthritis is increased early in the course of disease, as a result of ischaemic heart disease and pulmonary fibrosis. Rheumatology 46:350–357

    Article  PubMed  CAS  Google Scholar 

  2. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF (1986) Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 29:706–713

    Article  PubMed  CAS  Google Scholar 

  3. Kelly CA, Hamilton J (2007) What kills patients with rheumatoid arthritis. Rheumatology 46:183–184

    Article  PubMed  CAS  Google Scholar 

  4. Coyne P, Hamilton J, Heycock C, Saravanan V, Coulson E, Kelly CA (2007) Acute lower respiratory tract infections in patients with rheumatoid arthritis. J Rheumatol Sept 34(9):1832–1837

    CAS  Google Scholar 

  5. Riise T, Jacobsen BK, Gran JT, Haga HJ, Arnesen E (2001) Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol 20:123–127

    Article  PubMed  CAS  Google Scholar 

  6. Franklin J, Lunt M, Bunn D, Symmons D, Silman A (2007) Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 66:308–312

    Article  PubMed  Google Scholar 

  7. Capell HA, Murphy EA, Hunter JA (1991) Rheumatoid arthritis: workload and outcome over 10 years. Q J Med 79:461–476

    PubMed  CAS  Google Scholar 

  8. Doran M, Crowson CS, Pond GR, O’Fallon M, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287–2293

    Article  PubMed  Google Scholar 

  9. Doran M, Crowson CS, Pond GR, O’Fallon M, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46:2294–2300

    Article  PubMed  Google Scholar 

  10. Housden MM, Bell G, Heycock C et al (2010) How to reduce mortality from chest infections in rheumatoid arthritis. Clin Med 29:326–329

    Google Scholar 

  11. Tishler M, Caspi D, Almog Y, Seqal R, Yaron M et al (1992) Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjögren's syndrome. Ann Rheum Dis 51:604–606

    Article  PubMed  CAS  Google Scholar 

  12. Aletaha D, Neogi T, Silman A et al (2012) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588

    Article  Google Scholar 

  13. Griebling TL (2007) Urinary tract infections in women. In: Litwin MS, Saigal CS (eds) Urologic diseases in America. US Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington (D. C.): US Government Printing Office 2007: pp. 587–620. Available from http://kidney.niddk.nih.gov/statistics/uda/Urinary_Tract_Infection_in_Women-Chapter18.pdf. Accessed 23 Mar 2007

  14. Sheskin DJ (2004) Handbook of parametric and nonparametric statistical procedures, 3rd edn. Chapman & Hall CRC, Boca Raton

    Google Scholar 

  15. Wolfe W, Caplan L, Michaud K (2006) Treatment for rheumatoid arthritis and the risk of hospitalisation for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs and anti-tumour necrosis factor therapy. Arthritis Rheum 54:628–634

    Article  PubMed  CAS  Google Scholar 

  16. Vandenbroucke JP et al (1984) Survival and cause of death in rheumatoid arthritis: 25 year prospective follow up. J Rheumatol 11:158–161

    PubMed  CAS  Google Scholar 

  17. Ebringer A, Rashid T (2006) Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection. Clin Dev Immunol 13:41–48

    Article  PubMed  CAS  Google Scholar 

  18. Coulson E, Saravanan V, Heycock C, So KL, Morgan L, Hamilton J et al (2011) Pneumococcal antibody levels after Pneumovax in patients with rheumatoid arthritis on methotrexate. Ann Rheum Dis 48:1289–1291

    Article  Google Scholar 

  19. McLean-Tooke A, Aldridge C, Waugh S, Spickett G, Kay L (2009) Methotrexate, rheumatoid arthritis and infection risk—what is the evidence? Rheumatology 48:867–871

    Article  PubMed  CAS  Google Scholar 

  20. Doe S, Pathare S, Kelly CA, Heycock CR, Binding J, Hamilton J (2007) Uptake of influenza vaccination in immunosupressant agents for rheumatological diseases: a follow-up audit of the influence of secondary care. Rheumatology 46:716–717

    Google Scholar 

  21. Lanternier F, Henegar H, Mouthon L, Blanche P, Guillevin L, Launay O (2008) Low influenza vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis 67:1007

    Google Scholar 

  22. Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatol Oxf 45:106–111

    Article  CAS  Google Scholar 

  23. Van der Veen MJ, van der Heide A, Kruize AA, Biljsma JW (1994) Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 53:224–228

    Article  PubMed  Google Scholar 

  24. Luzi G, Laganà B, Salemi S, Di Rosa R et al (2009) Are glucocorticoids a consistent risk factor for infections in rheumatoid arthritis patients under treatment with methotrexate and etanercept? Clin Ter 160:121–123

    PubMed  CAS  Google Scholar 

  25. Joint Formulary Committee (Great Britain), British Medical Association, Royal Pharmaceutical Society of Great Britain (1997) British National Formulary. Issue 34; 564

  26. Au K, Reed G, Curtis J et al (2011) High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis 70:785–791

    Article  PubMed  Google Scholar 

  27. Eriksson I, Gustafson Y, Fagerström L, Olofsson B et al (2010) Prevalence and factors associated with urinary tract infections in very old women. Arch Gerontol Geriatr 50:132–135

    Article  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. A. Kelly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puntis, D., Malik, S., Saravanan, V. et al. Urinary tract infections in patients with rheumatoid arthritis. Clin Rheumatol 32, 355–360 (2013). https://doi.org/10.1007/s10067-012-2129-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-012-2129-7

Keywords

Navigation